Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
University of Delaware seeks a Director of Technical Operations for NIIMBL to lead all technical operations, safety, and asset management for a multi-partner biopharmaceutical program. You will oversee a diverse lab team, ensure regulatory compliance, and partner with leadership to align projects with industry and government expectations.
The role requires extensive GxP experience, strong leadership, and the ability to coordinate across universities, government agencies, and industry
Job no: 503941
College / VP Area: Research Office
Work type: Staff
Location: Newark, DE
Categories: Research & Laboratory, Full Time, Program/Project Management
Pay Grade: 90E
Under the limited direction of the Institute Director, the Director, Technical Operations is accountable for all technical operations including laboratory infrastructure, safety, and oversight of a team of individuals. In the future, this team may be working three shifts with 365 day per year operations at the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The work involves tactical decision-making to support safe and effective laboratory operations.
NIIMBL is a large-scale effort dedicated to supporting the manufacturing of biopharmaceuticals, and it is established by a cooperative agreement with the National Institute of Standards and Technology (NIST) as a public/private consortium of a diverse set of member organizations, including industry, academia, non-profit organizations, state governments, and federal agencies. NIIMBL is a member of the Manufacturing USA network of institutes funded by the federal government to advance United States competitiveness in advanced manufacturing innovation. Institutionally at the University of Delaware, NIIMBL reports to the Vice President for Research, Scholarship & Innovation.
The most high-profile activities that NIIMBL does are the execution of technical projects to advance the readiness levels of relevant technologies, assays, and methods. These projects include scopes of scientific work that generally include many organizations as partners and collaborators. For example, a project may involve experimental studies, at a level consistent with best practices found in the biopharmaceutical industry, and include scientists from several large and small companies, a scientist from a Federal agency, and a scientist from a University. Many of these projects will be hosted at the University of Delaware in a state-of-the-art laboratory facility purpose-built for such studies. These projects will involve a diverse set of technologies and approaches and address drug substance, drug product, and analytical needs by the industry appropriate to several types of biopharmaceuticals: vaccines, therapeutic proteins and antibodies, bispecific antibodies, and gene therapy vectors, among others. To accelerate innovation and support standards development, the Tech Ops team hosts and performs NIIMBL technical work that is best done at HQ because the work requires a collaborative environment and is work most effectively performed at a neutral site; this is a full-time, in person, position.
The University of Delaware does not discriminate against any person on the basis of race, color, national origin, sex, gender identity or expression, sexual orientation, genetic information, marital status, disability, religion, age, veteran status or any other characteristic protected by applicable law in its employment, educational programs and activities, admissions policies, and scholarship and loan programs as required by Title IX of the Educational Amendments of 1972, the Americans with Disabilities Act of 1990, Section 504 of the Rehabilitation Act of 1973, Title VI and VII of the Civil Rights Act of 1964, and other applicable statutes and University policies. The University of Delaware also prohibits unlawful harassment including sexual harassment and sexual violence.